Company news
Rigel Pharmaceuticals, Inc. news in 2021
Rigel Pharmaceuticals, Inc.'s news releases, calls and decks from 2021, newest first.
Rigel Appoints Kamil Ali-Jackson to Board of Directors
December 15, 2021
Rigel Sharpens Focus on Its Advanced Portfolio Opportunities
November 14, 2021
Rigel Reports Third Quarter 2021 Financial Results and Provides Business Update
November 1, 2021
Rigel Pharmaceuticals Provides Update on COVID-19 Program
August 12, 2021
Rigel Reports Second Quarter 2021 Financial Results and Provides Business Update
August 2, 2021
Rigel Announces Conference Call and Webcast to Report Second Quarter 2021 Financial Results and Business Update
July 26, 2021
Rigel Appoints Alison L. Hannah, M.D. to Board of Directors
May 13, 2021
Rigel Reports First Quarter 2021 Financial Results and Provides Business Update
May 4, 2021
Rigel Announces Conference Call and Webcast to Report First Quarter 2021 Financial Results and Business Update
April 27, 2021
Rigel Announces Closing of Strategic Collaboration with Lilly
April 6, 2021
Rigel Announces Completion of Patient Enrollment for NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients
March 10, 2021
Rigel Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
March 1, 2021
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2020 Financial Results and Business Update
February 22, 2021
Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
January 28, 2021